United Therapeutics (UTHR) Tops Q3 EPS by 194c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $497.59 --0%
EPS Growth %: -10.1%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -10.1%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.91, $1.94 better than the analyst estimate of $1.97. Revenue for the quarter came in at $330 million versus the consensus estimate of $335.1 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Morgan Stanley refreshes Strait of Hormuz reopening analysis
- General Mills beats estimates as cost savings offset volumes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
